[Medical considerations on the treatment of metastasizing mammary carcinoma (author's transl)].
The routine therapy of metastasizing mammary carcinoma at the present time is reported. The course of the treatment is considered in every case in connection with the mental problems of the patient which are partly caused by the often drastic treatment measures carried out. The methods of local radiation therapy, which is combined with ablative hormonal methods or, in cases of progressive metastasization, with added exogenous hormones, estrogens, androgens or anabolics, is explained in detail. The final part of the paper is devoted to the currently used polychemotherapy which replaces the hormonal methods in progressive metastasization.
D000328:Adult; D000367:Age Factors; D045930:Anabolic Agents / Q000627:therapeutic use; D000728:Androgens / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000175:diagnosis / Q000532:radiotherapy; D001943:Breast Neoplasms / Q000628:therapy*; D002369:Castration; D004359:Drug Therapy, Combination; D004967:Estrogens / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008593:Menopause; D008875:Middle Aged; D009362:Neoplasm Metastasis / Q000628:therapy*; D010166:Palliative Care; D010347:Patient Care Planning; D011877:Radionuclide Imaging; D011879:Radiotherapy Dosage; D013667:Technetium
D045930:Anabolic Agents; D000728:Androgens; D000970:Antineoplastic Agents; D004967:Estrogens; D013667:Technetium
Arztliche Uberlegungen bei der Behandlung des metastasierten Mammakarzinoms